 NAPLES, Fla., Jan. 15, 2021 PRNewswire -- Enveric Biosciences, Inc. NASDAQ: ENVB Enveric or the Company, a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced the closing on January 14, 2021,... 